Washington Trust’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-744
Closed -$17K 617
2025
Q1
$17K Hold
744
﹤0.01% 543
2024
Q4
$18.8K Hold
744
﹤0.01% 587
2024
Q3
$18.5K Hold
744
﹤0.01% 599
2024
Q2
$22.1K Hold
744
﹤0.01% 561
2024
Q1
$22.4K Sell
744
-786
-51% -$21.8K ﹤0.01% 562
2023
Q4
$43.8K Sell
1,530
-3,248
-68% -$95.4K ﹤0.01% 447
2023
Q3
$177K Sell
4,778
-29
-0.6% -$1.11K 0.01% 251
2023
Q2
$188K Sell
4,807
-238
-5% -$9.33K 0.01% 258
2023
Q1
$184K Sell
5,045
-2,068
-29% -$65.3K 0.01% 262
2022
Q4
$219K Buy
+7,113
New +$221K 0.01% 243

Other funds holding RTO

Washington Trust's RTO Position: Q2 2025 in Review

Washington Trust sold out of Rentokil (RTO) in Q2 2025, closing a stake of 744 shares — an estimated $17K sold.

Washington Trust first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $219K in Q4 2022. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Washington Trust reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Washington Trust sold 744 Rentokil shares in Q2 2025, an estimated $17K.
  • Washington Trust first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • Washington Trust's Rentokil position peaked at $219K in Q4 2022.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Washington Trust's 13F filing for Q2 2025, filed 8 Aug 2025.